Telesis Bio, Inc
https://codexdna.com/
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Latest From Telesis Bio, Inc
Big Pharma Deal Hunters Target RNA Approaches In Race To Build Best Platforms
The potential for RNA medicines to achieve holy grail goals – reaching undruggable targets and bringing drugs to market faster – has Pfizer, Lilly, Novartis and others in a deal-making frame of mind.
Pfizer Shopping For Deals That Will Add $25bn To 2030 Revenues
With cash to spend and a patent cliff to overcome starting in 2025, Pfizer is expected to be a prolific deal-maker in 2022.
Company Information
- Industry
-
Research, Analytical Equipment & Supplies
- PCR & Amplification Tools
-
Biotechnology
- Drug Discovery Technologies
- Synthesis Technologies, Production Processes
- Other Names / Subsidiaries
-
- SGI-DNA Inc.
- Synthetic Genomics Solutions, Codex DNA, Inc
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Email Company
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice